Healthcare -
Biotechnology - NASDAQ - US
$ 4.1375
-0.541 %
$ 86.1 M
Market Cap
-0.7
P/E
ADVM - CAPITAL EXPENDITURES
Capital Expenditures ADVM - Adverum Biotechnologies, Inc.
-808 K
LAST VALUE
76.89%
2 YEAR CAGR
0.02%
5 YEAR CAGR
-24.40%
10 YEAR CAGR